Coronary stents are small, expandable metal or plastic tubes used to treat coronary artery disease. They help keep arteries open and improve blood flow to the heart. Stents are often used in conjunction with balloon angioplasty procedures to open blocked or narrowed heart arteries. Bioresorbable coronary stents dissolve naturally over time, eliminating the need for long-term dual antiplatelet therapy.
The global coronary stents market is estimated to be valued at US$ 9.16 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2028.
Key Takeaways
Key players: Key players operating in the coronary stents market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology, and B Braun Melsungen.
Key opportunities: Increasing prevalence of Coronary Stents Market Size , rising geriatric population, and surge in obesity rates are expected to present lucrative opportunities for market players. Advancements in bioresorbable stent technology is also expected to aid market growth over the forecast period.
Technological advancements: The approval and launch of innovative bioresorbable stents and drug-eluting stents has transformed the treatment of coronary artery disease. Ongoing R&D in biodegradable polymers and resorbable scaffolds hold promise.
Market drivers: Rapid urbanization, sedentary lifestyles, and unhealthy eating habits have led to rising cardiac disorders. Favorable reimbursement policies and initiatives by governments worldwide to spread awareness about heart health are some of the key factors boosting the global coronary stents market.
Get more insights on - Coronary Stents Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian